Optimal dose and safety of molnupiravir in patients with early SARS

The recommended dose of molnupiravir is 800mg taken orally every 12 hours for 5 days Treatment must not be extended

Molnupiravir was safe and well tolerated; a dose of 800mg twice-daily for 5 days was recommended for Phase II evaluation Background AGILE is a phase IbIIa

molnupiravir กินยังไง Safety was assessed in all participants who took at least one dose of the medication The viral clearance rate was derived under a Bayesian

molnupiravir dose Conclusion Molnupiravir was safe and well tolerated; a dose of 800mg twice-daily for 5 days was recommended for Phase II evaluation